Sarraju, A;
Li, J;
Cannon, CP;
Chang, TI;
Agarwal, R;
Bakris, G;
Charytan, DM;
... Mahaffey, KW; + view all
(2021)
Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes in Participants With Type 2 Diabetes and Chronic Kidney Disease According to History of Heart Failure: Results From the CREDENCE Trial.
American Heart Journal
, 233
pp. 141-148.
10.1016/j.ahj.2020.12.008.